β³ Fetching live dividend data...
Home βΊ Calculator βΊ ANNX Dividend Calculator 2026
Annexon, Inc. Β· NASDAQ
Price: $5.46 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ANNX β $14.1K in 10 years Β· $0.42/month
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmic conditions. Central to its approach is the C1q molecule, which initiates the classical complement pathway. The company targets this pathway to address specific disease mechanisms, such as those seen in antibody-mediated autoimmune disorders and complement-driven neurodegeneration. The company's developmental pipeline features several promising candidates. ANX005, a monoclonal antibody, is in advanced clinical testing, undergoing Phase II/III trials for Guillain-BarrΓ© syndrome, as well as Phase II trials for warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis. Another candidate, ANX009, is currently in Phase Ib studies for lupus nephritis. Additionally, ANX007 is progressing through Phase II clinical trials for the treatment of geographic atrophy, an eye disease. Further investigational assets include ANX105, a monoclonal antibody being developed for neurodegenerative indications, and ANX1502, an oral small molecule under investigation for specific autoimmune conditions. Annexon, Inc. was established in 2011 and operates from its headquarters in Brisbane, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ANNX position with:
Real after-tax yield depends on where you live and how you hold ANNX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 36.63% | 33.83% | $3,663 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 31.14% | 28.34% | $3,114 / yr |
| πΊπΈ US Taxable (20%) | 20% | 29.30% | 26.50% | $2,930 / yr |
| π¬π§ UK ISA | 0% | 36.63% | 33.83% | $3,663 / yr |
| π¬π§ UK Taxable | 8.75% | 33.42% | 30.62% | $3,342 / yr |
| π¨π¦ TFSA | 0% | 36.63% | 33.83% | $3,663 / yr |
| π¨π¦ CA Taxable | 25% | 27.47% | 24.67% | $2,747 / yr |
| π¦πΊ Super (pension) | 15% | 31.14% | 28.34% | $3,114 / yr |
| π¦πΊ AU Taxable | 30% | 25.64% | 22.84% | $2,564 / yr |
| π©πͺ DE Taxable | 26.375% | 26.97% | 24.17% | $2,697 / yr |
| π«π· FR Taxable | 30% | 25.64% | 22.84% | $2,564 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
ANNX pays quarterly β 4 times per year. Next ex-div: TBD.
How ANNX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ANNX sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-11 | 65,000 | $4.70 | $305.5K | ||
| A-Award | 2026-06-11 | 65,000 | $4.70 | $305.5K | ||
| A-Award | 2026-06-11 | 65,000 | $4.70 | $305.5K | ||
| A-Award | 2026-06-11 | 65,000 | $4.70 | $305.5K | ||
| A-Award | 2026-06-11 | 65,000 | $4.70 | $305.5K | ||
| A-Award | 2026-06-11 | 65,000 | $4.70 | $305.5K | ||
| M-Exempt | 2026-06-11 | 30,646 | $1.85 | $56.7K | ||
| M-Exempt | 2026-06-11 | 30,646 | $1.85 | $56.7K | ||
| Buy | 2026-05-28 | 613,497 | $5.41 | $3.32M | ||
| Buy | 2026-05-11 | 8,000 | $5.78 | $46.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers β historically a positive signal for dividend sustainability. Last purchase: 2026-05-28
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ANNX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Annexon, Inc. (ANNX) is currently trading at $5.46, 82% below its 52-week high. The current dividend yield is 36.63% based on an annual payout of $2.00 per share.
Annexon, Inc. (ANNX) is a healthcare stock currently trading at $5.46 with a dividend yield of 36.63%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, ANNX has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β